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Kolvenbach, MD, Düsseldorf, Germany
Objective: Carotid artery stenting is emerging as an attractive alternative to surgical endarterectomy for the treatment of
carotid artery disease. This study reports our initial experience using the radial artery as access for carotid stenting.
Methods: A retrospective study was performed in which 20 consecutive patients at high risk for carotid endarterectomy
underwent carotid stenting with cerebral protection using radial artery access. All procedures were performed in the
operating room from March 2006 to December 2006. Seven lesions were symptomatic, and 13 lesions were asymptom-
atic. Patients were evaluated for development of stroke or transient ischemic attacks, myocardial infarction, access site
complications, procedural success, time to patient mobilization, and need for intravenous analgesia.
Results: Procedural success was achieved in 18 patients (90%). Intense radial artery vasospasm resulted in one failure, and
the second failure occurred in a patient with a left-sided carotid lesion and type I arch. The 30-day incidence of stroke,
transient ischemic attacks, myocardial infarction, and death was 0%. Radial artery occlusion only occurred in the one
patient because of the development of intense vasospasm during the procedure. One patient had persistent local pain
requiring intravenous medication for relief. All patients were mobilized<2 hours of intervention and were discharged on
the first postoperative day.
Conclusions: Carotid artery stenting with cerebral protection devices can be safely and effectively performed, with
acceptable morbidity and high technical success, by using radial artery access. We recommend obtaining imaging of the
aortic arch and supra-aortic trunks with computed tomography, as well as a duplex scan of radial artery, before
attempting carotid artery stenting using radial artery access. Further study is needed before recommending that femoral
access be replaced by radial access for carotid artery intervention. (J Vasc Surg 2007;45:1136-41.)Stenting of the internal carotid artery has gained wide
acceptance in the treatment of occlusive disease of the
extracranial cerebral arteries.1 The results are constantly
improving because of the introduction of new embolic
protection devices and small caliber catheter and stenting
systems. The conventional way to access the common
carotid artery (CCA) during endovascular interventions is
through the femoral artery; however, this approach is not
always possible because of vessel pathology or aberrant
anatomy in the iliofemoral arteries and the aortic arch. A
transbrachial or a direct transcervical approach can be used
as an alternative when femoral access is not possible.
We have performed carotid artery stenting (CAS) in
our hospital since 2001. We initially used the transcervical
approach if femoral access was not possible. We decided to
start using transradial access for CAS after several successful
cerebral angiographies were performed by radial artery
access. In this article, we report our early experience with
transradial access and CAS. We also describe our technique
and provide a review of the literature.
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1136MATERIALS AND METHODS
During the study period (March 2006 to December
2006), 46 patients were treated with carotid stents. This
study is a retrospective review of 20 consecutive patients in
whom CAS was performed by using transradial access.
These 20 consecutive patients were treated by the first
(L. P.) and senior authors (R. K.) in the institution. All
patients underwent CAS because they were considered
high risk for open carotid endarterectomy.
The grade of carotid stenosis was determined by use of
preoperative duplex ultrasonography, computed tomo-
graphic angiography (CTA), or magnetic resonance an-
giography (MRA), but the degree of stenosis was always
verified by intraoperative angiography. All CAS procedures
were performed in the operating room using a portable
C-arm (OEC 9800 Plus, General Electric Medical Systems,
Waukesha, Wis).
All patients provided informed consent before any in-
tervention. The major complications (30 days) evaluated
were perioperative myocardial infarction, stroke, transient
ischemic attacks (TIAs), and death. Also evaluated were
technical success, peripheral nerve injury, access site hema-
toma, radial artery occlusion, pain, and early ambulation.
Description of technique. An Allen’s test is per-
formed in every patient before transradial access. The test
result is considered normal (negative Allen’s test) if the
palm color returns to normal 10 seconds.2 The right arm
of the patient is positioned on an arm holder, abducted at
45°. The wrist is hyperextended over a gel pad, and the arm
is prepared and draped to the axilla. After access is gained,
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operators or placed parallel to the body to facilitate catheter
manipulations for right-handed operators. Local anesthesia
is infiltrated along the distal radial pulse.
The artery is punctured with a Check-Flo micropunc-
ture radial artery access set (Cook, Indianapolis, Ind), and a
5F short sheath is introduced. Systemic unfractionated
heparin is administered intravenously to achieve an acti-
vated clotting time of 350 seconds, and a spasmolytic
“cocktail” of 200 g of nitroglycerin and 2.5 mg of vera-
pamil is given intra-arterially through the side arm of the
sheath to prevent spasm secondary to vessel manipulation.
It is necessary to use multiple views to optimize visual-
ization of the carotid anatomy. We use variable projections
and patient head positions to obtain the widest angle at the
carotid origin. The right or left CCA is cannulated with an
appropriately shaped diagnostic catheter and hydrophilic
guidewire. We prefer to use the internal mammary artery
(IMA), and Simmons 1 or Berenstein catheter configura-
tions for cannulation of the right CCA. All selective cathe-
ters are Imager II from Boston Scientific, Natick, Mass. For
cannulation of the left CCA in patients with bovine arch
anatomy, we use the Berenstein or JB1 catheter (Imager II)
configurations. For cannulation of the left CCA in patients
with standard (normal) aortic arch anatomy, we prefer to
use the Simmons 2 (Imager II) selective diagnostic cathe-
ter.
The catheter is then advanced just proximal to the
carotid bifurcation and an Amplatz Super Stiff (Boston
Scientific) wire is positioned in the external carotid artery to
provide support for the subsequent sheath exchange. In
cases of angulated, tortuous aortic branch vessels, where
access with the Super Stiff wire cannot be maintained, we
use a telescope technique in which a hydrophilic 0.035-
inch (260 cm) Glidewire (Terumo Medical Corporation,
Tokyo, Japan) is used to advance a diagnostic angiography
catheter into the distal CCA.
The selected guiding sheath is then advanced over the
catheter–wire combination just proximal to the carotid
bulb. We use a 6F or 7F, 90-cm hydrophilic guide sheath;
either a Terumo Destination carotid guiding sheath or a
Shuttle SL Flexor with a Tuohy-Borst sidearm (Cook). The
size of the guide sheath must accommodate the carotid
stent platform (usually 5F or 6F) and allow for continuous
flushing with heparinized saline and adequate contrast ad-
ministration during the procedure. We have found that
using matched French sizes for the guide sheath and the
carotid stent limits our ability to perform adequate flushing
and contrast injections; thus, we oversize the guide sheath
by one French size in relation to the carotid stent system
that is utilized.
Roadmap angiography is performed to confirm that the
degree of stenosis is 60%. The degree of angiographic
carotid artery stenosis is calculated according to North
American Symptomatic Carotid Artery Endarterectomy
Trial (NASCET) criteria.3
The embolic protection device is deployed in the usual
fashion, and after administration of 1 mg of intravenousatropine, predilatation of the carotid stenosis with a small
diameter (3.0 or 3.5 mm) angioplasty balloon (Ultrasoft
SV, Boston Scientific) is performed if necessary to facilitate
positioning of the carotid stent. The carotid stent is de-
ployed and postdilated with a 5.0-mm-diameter angio-
plasty balloon (Ultrasoft SV, Boston Scientific), if neces-
sary. We prefer to use the Zilver Stent (Zilver 518, Cook)
because of the very low profile (5F), but we have also used
6F systems such as the Carotid Wallstent Monorail (Boston
Scientific) or Precise Stent (Cordis Corp, Miami, Fla).
After completion angiography, the protection system
and the sheath are removed without reversal of anticoagu-
lation. The puncture site is compressed by hand for 5
minutes. We then use a 5-mL syringe, with both ends cut
off that has been wrapped with gauze, to maintain pressure
on the radial artery puncture site for 6 hours. The syringe is
positioned longitudinally along the course of the distal
radial artery and held in place with a noncircumferential
elastic tape.
The patient is moved to the postoperative care unit for
2 hours and then sent to the ward. The patient’s neurologic
status is evaluated by the interventionalist at the completion
of the procedure, at removal of the bandage, before dis-
charge, and at 30-day follow-up. If a neurologic deficit is
observed, then a neurologist is consulted to evaluate the
patient.
Patients are allowed to ambulate and eat without re-
strictions. They are kept for observation for one night in the
hospital and discharged home on the first postoperative
day. The radial pulse is palpated, and the adequacy of the
hand’s blood supply is evaluated clinically when the dress-
ing is removed, at the time of discharge, and at 30-day
follow-up.
RESULTS
The mean age of the treated patients (14 men, 6
women) was 72 years (range, 62 to 84 years). Seven pa-
tients were symptomatic (TIAs or stroke, or both; 60%
stenosis). Thirteen patients were asymptomatic but had
high-grade stenosis (80%) on CTA, MRA, or conven-
tional duplex ultrasonography. We did not exclude patients
from transradial access (TRA) on the basis of preoperative
imaging. The patients had the following comorbidities:
65% were smokers, 30% were diabetic, 70% were hyperten-
sive, 45% had coronary artery disease, and 40% were hyper-
cholesterolemic (see Table I). In 12 patients, the right
carotid bifurcation had disease. Eight patients had left sided
carotid stenosis, and four also had a bovine arch. Type I
arch anatomy was present in 16 patients, and four had type
II arch anatomy.4
We were able to successfully complete the CAS proce-
dure using transradial access in 18 of 20 patients (90%
technical success rate). The mean procedure time was 67
minutes (range, 45 to 90 minutes). In 15 patients, one
diagnostic catheter was used, and two diagnostic catheters
were used in three patients. Themean fluoroscopy time was
17 minutes (range, 11 to 29 min).
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tient that precluded passage of the guiding sheath. This
patient was a 70-year-old man with diabetes who had a very
calcified radial artery. After removal of the 7F sheath, we
were unable to palpate a radial pulse proximal to the
puncture site, but there was a Doppler signal in the palmar
arch and no sign of hand ischemia. In the other patient, the
left CCA could not cannulated. This patient had a type I
arch, and despite three catheter exchanges, we were unable
to cannulate the orifice of the left CCA and the procedure
was aborted (Fig 1).
No perioperative myocardial infarctions, strokes, TIAs,
or deaths occurred (Table II). In the patient where radial
artery spasm prevented completion of the procedure, the
radial artery occluded postoperatively, but the patient re-
mained asymptomatic. All other patients had clinically
patent access arteries at the time of discharge and at the
30-day follow-up. No access site hematomas developed
that required surgical evacuation. One patient had incapac-
itating pain requiring intravenous analgesia. All patients
were ambulatory 2 hours of intervention. There were no
instances of peripheral nerve injury or digital ischemia. All
patients were discharged home on the first postoperative day.
DISCUSSION
Systematic reviews of observational studies provide
considerable data to support the performance of CAS.1
According to a publication by Burton and Lindsay,5 in
which 2992 patients were evaluated in 26 studies from
2002 to 2004, CAS is associated with an adverse event rate
of 2.4%  0.3%, which is comparable to that of current
carotid endarterectomy.5-9
Most interventionists prefer to use the transfemoral
approach for access. This method provides adequate access
in most situations and allows traversal of the arch and
negotiation of acute angles at the ostia of the great vessels.
Femoral access is not possible in some patients. Extensive
atherosclerotic disease in the aortic arch, atypical aortic arch
anatomy, dissection of the thoracic aorta, iliofemoral occlu-
sive disease, and infection in the groin are some of the
Table I. Patient demographic data
Characteristic No. of patients (%)
Symptomatic 7 (35)
Asymptomatic 13 (65)
Smoking 13 (65)
Diabetes 6 (30)
Hypertension 14 (70)
Coronary artery disease 9 (45)
Hypercholesterolemia 8 (40)
Carotid artery disease
Right 12 (60)
Left 8 (40)
Bovine arch 4 (20)
Type I arch 16 (80)
Type II arch 4 (20)limitations for femoral access. In such cases, alternate accesssites need to be considered, such as transcervical, transbra-
chial, or transradial.
The transcervical approach is more invasive because it
usually requires a small cervical incision to prevent poten-
tially disastrous access site complications and ensure hemo-
stasis due to the lack of percutaneous carotid puncture
closure systems at present.
The transbrachial approach may also be difficult to
perform and can result in severe complications, including
brachial sheath hematoma, compartment syndrome, injury
to the median nerve, or ischemia to the hand.10 Major
access site complications were more frequently encoun-
tered during coronary artery stenting (CAS) after transbra-
chial and transfemoral puncture compared with transradial
access according to the Access study.11
Significant benefit in favor of transradial access was
found in the multicenter randomized Access study compar-
ing transfemoral, transbrachial, and transradial approaches
for coronary artery stenting. Radial access was associated
with fewer major complications (2.0 % for transfemoral,
2.3% for transbrachial, 0% for transradial) and had the same
technical success rate (91% to 92%) as transfemoral and
transbrachial access. Percutaneous transradial coronary an-
gioplasty led to asymptomatic loss of the radial pulse in
approximately 3% of patients. As carotid stenting devices
become increasingly more pliable and lower in profile, the
percentage of periprocedural radial artery occlusions is ex-
pected to decrease.
The right transradial approach is particularly efficacious
for cannulation of the right CCA or the left CCA in the
presence of a bovine arch because it minimizes the risk of
particulate embolization. The advantage of the right trans-
radial approach is the avoidance of catheter manipulations
in the aortic arch, because there is no need to negotiate the
ostia of the arch vessels.
The incidence of cerebral embolization during CAS
procedures using a transfemoral approach was analyzed by
Hammer et al.12 Their study demonstrated that 40% of the
patients had new ischemic lesions in postoperative diffu-
sion-weightedMRI, and that 62% of the cases with positive
diffusion-weighted MRI had embolic lesions that were
found outside the vascular territory of the treated internal
carotid artery, thus suggesting embolization from the aor-
tic arch. Cannulation of the left CCA in patients with type
I arch anatomymay bemore difficult or impossible through
the right radial artery. If this is the case, standard femoral
access can be used for CAS procedure. We now perform
preoperative CTA and MRA to evaluate aortic arch anat-
omy that might preclude successful transradial access.
The use of the transradial approach for coronary an-
giography was first described by Lucien Campeau in
1989.13 The safety and feasibility of this approach in coro-
nary angioplasty and stenting have been reported in several
studies.14,15 As a consequence of these favorable initial
results and reduced bleeding risk, despite use of potent
antithrombotic and platelet therapy, transradial access for
coronary intervention has gained widespread worldwide
acceptance. Transradial access provides excellent postoper-
JOURNAL OF VASCULAR SURGERY
Volume 45, Number 6 Pinter et al 1139ative comfort for the patient, with practically immediate
ambulation after the procedure. Researchers have even
found a cost reduction in several studies because of the low
incidence of complications, no need for a closure devices,
and reduced length of stay.16,17
Use of transradial access for CAS has been reported in
sporadic case reports.18,19 Despite excellent results, this
method has not gained widespread acceptance. The reasons
for the infrequent use of transradial access for CAS may
have been the large, inflexible, first-generation stenting
systems and sheaths. Devices have quickly been developed,
however, that are hydrophilic, flexible, kink-resistant, and
that have low profiles (5F to 6F). These technical improve-
ments should facilitate use of TRA access. The mean radial
artery internal diameter is 3.1 0.60mm inmen and 2.8
Fig 1. Computed tomographic angiographic images o
stenosis. Carotid stenting was not successful using tran
artery could not be cannulated.
Table II. Postoperative outcomes
Outcome No. of Patients (%)
Stroke/transient ischemic attack 0 (0)
Acute myocardial infraction 0 (0)
Radial artery occlusion 1 (5)
Incapacitating pain 1 (5)
Surgical hematoma 0 (0)
Mobilization in 2 hours 20 (100)0.60 mm in women.20 Further downsizing of carotid stentsshould theoretically allow most patients to accommodate
the procedure through transradial access.
Similar to every method in the beginning, the transra-
dial access technique also has a learning curve. The punc-
ture of this relatively small-caliber artery is not always easy.
The radial artery is very vasoreactive and tends to spasm;
therefore, it is important to try to achieve entry on the first
puncture. The radial artery has a small lumen, but its
muscular wall dilates to accommodate 8F diameter
sheaths.21,22 It is very important to administer spasmolytic
medication (isosorbide dinitrate, lidocaine, or verapamil)
intra-arterially immediately after the puncture. This will
decrease the incidence of vasospasm and radial artery occlu-
sion from 60% to 3%.2 Periprocedural pain and paresthesias
may be considerably reduced by the use of micropuncture
systems to access the radial artery.
Complications at the radial artery puncture site are
extremely rare owing to the anatomy of the wrist. The
median nerve courses apart from the artery in this location;
therefore, it is almost impossible to cause an injury to the
nerve. There have been reports of inflammatory reaction
with granuloma formation in patients who had transradial
coronary artery catheterization using hydrophilic sheaths.
This complication occurred in 1.6% of patients during a
3-year period, but despite severe initial pain, there were no
ent with (A) type I arch anatomy and (B) left carotid
l access because the orifice of the left common carotidf pati
sradiaadverse long-term sequelae.23
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fore, it is relatively easy to access and compress. Ease and
effectiveness of compressibility are vital for interventions
where patients have received anticoagulation medica-
tion. In cases of postoperative bleeding after radial ac-
cess, patients are able to recognize and control the
bleeding themselves. Even when the radial artery oc-
cludes, the hand is not jeopardized because of the dual
blood supply through the ulnar artery and palmar arch.
Most patients remained asymptomatic despite radial ar-
tery occlusion if they had a negative (normal) Allen’s
test, and it is notable that the radial pulse had returned to
normal at the 1-month follow-up in half of the patients.2
A properly performed and documented Allen’s test is
imperative before use of transradial access.
The contraindications to use of transradial access are a
nonpalpable radial pulse, a positive (abnormal) Allen’s test,
calcinosis, and need to maintain the radial artery for dialysis
access. Radial artery size and degree of calcinosis can be
determined by preoperative duplex evaluation. In this pilot
study, we did not perform duplex evaluation of our pa-
tients’ radial arteries; however, after further review of our
results and the literature, we now recommend obtaining a
duplex study to evaluate size and suitability of the radial
artery before sheath insertion.
Contrary to public perception, Saito et al20 have pub-
lished that there is no relationship between radial artery
Fig 2. Algorithm for use of transradial access when p
tomographic angiography; MRA, magnetic resonance
carotid endarterectomy.internal diameter and weight, height, or patient body sur-face area. Stella et al2 also comment that there is no corre-
lation between gender and postprocedural radial artery
occlusion.2 We perform transradial access in patients with
noncalcified arteries sized2.5mm on duplex because that
size will accommodate the outer diameter of a 6F sheath.
CONCLUSION
Our early experience with transradial access confirms
that CAS can be effectively performed through this
approach with acceptable morbidity and with high tech-
nical success and patient satisfaction. We propose that
transradial access is a safe, ideal alternative to transfemo-
ral access and do not restrict its use just to patients with
difficult femoral access. We preferentially perform CAS
with transradial access in patients with right-sided ca-
rotid lesions and left-sided carotid lesions in the presence
of bovine or type II or III arch anatomy (Fig 2). We
recommend obtaining imaging of the aortic arch and
supra-aortic trunks with CTA and MRA, as well as a
duplex scan of radial artery before attempting CAS when
using transradial access. With this approach, patients
with unfavorable aortic arch and radial artery character-
istics that impact procedural success can be excluded. A
multicenter, randomized, controlled trial is needed to
definitively answer whether transradial access can replace
ming carotid artery stenting (CAS). CTA, Computed
graphy; RAID, radial artery internal diameter; CEA,erfor
angiotransfemoral access routinely during CAS.
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